NRX Pharmaceuticals, Inc. (NRXP)
4.445
+0.16
(+3.86%)
USD |
NASDAQ |
May 28, 16:00
4.40
-0.04
(-1.01%)
After-Hours: 17:22
NRX Pharmaceuticals Total Assets (Quarterly) : 11.90M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| IGC Pharma, Inc. | 9.185M |
| Definium Therapeutics, Inc. | 401.29M |
| Atai Beckley, Inc. | 264.88M |
| Alto Neuroscience, Inc. | 276.26M |
| LENZ Therapeutics, Inc. | 272.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.72M |
| Shareholders Equity (Quarterly) | -13.82M |
| Debt to Equity Ratio | -0.0676 |
| Current Ratio | 0.2924 |
| Net Debt Paydown Yield | 1.58% |